Page last updated: 2024-10-24

beta-glycerophosphoric acid and Adverse Drug Event

beta-glycerophosphoric acid has been researched along with Adverse Drug Event in 1 studies

beta-glycerophosphoric acid: plays role in mineralization of bone in vitro
glycerol 2-phosphate : A glycerol monophosphate having the phosphate group at the 2-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rezazadeh, M1
Jafari, N1
Akbari, V1
Amirian, M1
Tabbakhian, M1
Minaiyan, M1
Rostami, M1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
''Erythropoietin Gel as an Adjunct to Split-Thickness Apically Positioned Flap in Augmentation of Attached Gingiva'' (A Randomized Controlled Clinical Study)[NCT05683782]Phase 420 participants (Anticipated)Interventional2022-10-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for beta-glycerophosphoric acid and Adverse Drug Event

ArticleYear
A mucoadhesive thermosensitive hydrogel containing erythropoietin as a potential treatment in oral mucositis: in vitro and in vivo studies.
    Drug delivery and translational research, 2018, Volume: 8, Issue:5

    Topics: Animals; Cattle; Chitosan; Disease Models, Animal; Drug-Related Side Effects and Adverse Reactions;

2018